|
🐜
|
A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody
24 auth.
Andreas G. Bader,
David Brown,
Matthew Winkler,
E. Shim,
C. Livi,
D. Rakheja,
J. Tan,
Daniel R. Benson,
V. Parekh,
Eun-Young Kho,
...
Arindam Ghosh,
R. Kirkman,
S. Velu,
Shilpa Dutta,
B. Chenna,
S. Rea,
Robert J. Mishur,
Qiuhua Li,
T. Johnson-Pais,
Lining Guo,
S. Bae,
Shiqin Wei,
K. Block,
S. Sudarshan
|
7 |
2014 |
7
🐜
|
|
🐜
|
T Cell Lymphoma in Transgenic Mice Expressing the HumanHsp70Gene
8 auth.
Jeong-Sun Seo,
Young-Mee Park,
Jong-Il Kim,
E. Shim,
C. Kim,
Ja-june Jang,
...
Soon-Hee Kim,
Wonkyung Lee
|
6 |
1996 |
6
🐜
|
|
🦁
|
Targeted disruption of hsp70.1 sensitizes to osmotic stress
14 auth.
E. Shim,
Jong-Il Kim,
Eui‐Suk Bang,
Jun Heo,
Jae‐Seon Lee,
Eun‐Young Kim,
Jong‐Eun Lee,
Woong‐Yang Park,
Soon-Hee Kim,
Hyung-Suk Kim,
...
O. Smithies,
Ja‐Joon Jang,
Dong‐Il Jin,
Jeonghwa Seo
|
6 |
2002 |
6
🦁
|
|
🐜
|
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
9 auth.
Arindam Ghosh,
C. Marshall,
T. Coric,
E. Shim,
R. Kirkman,
M. Ballestas,
...
M. Ikura,
M. Bjornsti,
S. Sudarshan
|
5 |
2015 |
5
🐜
|
|
🐜
|
T cell lymphoma in transgenic mice expressing the human Hsp70 gene.
8 auth.
J. Seo,
Y. M. Park,
J. I. Kim,
E. Shim,
C. W. Kim,
J. Jang,
...
S. H. Kim,
W. H. Lee
|
5 |
1996 |
5
🐜
|
|
🐜
|
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer
25 auth.
S. Shelar,
E. Shim,
Garrett J. Brinkley,
A. Kundu,
F. Carobbio,
Tyler L Poston,
J. Tan,
V. Parekh,
Daniel R. Benson,
D. Crossman,
P. Buckhaults,
D. Rakheja,
R. Kirkman,
Yusuke Sato,
S. Ogawa,
...
Shilpa Dutta,
S. Velu,
E. Emberley,
Alison Pan,
Jason J. Chen,
Tony T. Huang,
D. Absher,
Anja Becker,
C. Kunick,
S. Sudarshan
|
5 |
2018 |
5
🐜
|
|
🐬
|
The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-κB Signaling*
Karthigayan Shanmugasundaram,
B. Nayak,
E. Shim,
C. Livi,
K. Block,
S. Sudarshan
|
5 |
2014 |
5
🐬
|
|
🐜
|
The p53-induced factor Ei24 inhibits nuclear import through an importin β–binding–like domain
8 auth.
K. G. Lieu,
E. Shim,
Jinling Wang,
R. Lokareddy,
T. Tao,
G. Cingolani,
...
G. Zambetti,
D. Jans
|
4 |
2014 |
4
🐜
|
|
🦁
|
Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer
E. Shim,
S. Sudarshan
|
4 |
2015 |
4
🦁
|
